Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Annales De Pathologie|April 4, 2020
[Hereditary breast carcinomas pathologist's perspective]Anne Vincent-Salomon, Guillaume Bataillon, Lounes Djerroudi
Clinical Case Reports|October 13, 2022
Upper-limb acute superficial lymphatic thrombosis: A case reportRémy Hamdan, Nicolas Briche, Vanessa Gasmi, et al.
European Journal of Radiology|July 18, 2024
Initial MRI findings predictive of a pathological complete response to neoadjuvant treatments in HER2-positive breast cancersAnne Ribrag, Emilie Lissavalid, Juliette Fayard, et al.
Cancers|August 7, 2021
Lobular Breast Cancer: Histomorphology and Different Concepts of a Special Spectrum of TumorsMatthias Christgen, Gábor Cserni, Giuseppe Floris, et al.
Frontiers in Genetics|June 21, 2021
Multi-Omics Marker Analysis Enables Early Prediction of Breast Tumor ProgressionHaifeng Xu, Tonje Lien, Helga Bergholtz, et al.
Annals of Nuclear Medicine|August 12, 2025
Are [18F]FDG PET/CT imaging and cell blood count-derived biomarkers robust non-invasive surrogates for tumor-infiltrating lymphocytes in early-stage breast cancer?Romain-David Seban, Louis Rebaud, Lounes Djerroudi, et al.
Histopathology|June 3, 2026
Landscape of genetic alterations affecting cancer genes in primary and advanced malignant phyllodes tumoursSelma Yeni Yildirim, Pier Selenica, Andrea Gazzo, et al.
Ultrasound in Medicine & Biology|June 25, 2022
Proof of Concept of 3-D Backscatter Tensor Imaging Tomography for Non-invasive Assessment of Human Breast Cancer Collagen OrganizationJean-Baptiste Guillaumin, Lounes Djerroudi, Jean-François Aubry, et al.
Ultrasound in Medicine & Biology|January 9, 2024
Biopathologic Characterization and Grade Assessment of Breast Cancer With 3-D Multiparametric Ultrasound Combining Shear Wave Elastography and Backscatter Tensor ImagingJean-Baptiste Guillaumin, Lounes Djerroudi, Jean-François Aubry, et al.
The Journal of Pathology. Clinical Research|April 2, 2024
The prognosis of patients treated with everolimus for advanced ER-positive, HER2-negative breast cancer is driven by molecular featuresHélène Salaün, Lounes Djerroudi, Laura Haik, et al.
Pageof 4